Continuity Biosciences, LLC · CIK 2029079
Continuity Biosciences, LLC
Filings
2
Original notices
2
Amendments
0
Activity
Jun 4, 2025
through Aug 19, 2025
through Aug 19, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jun 4, 2025 · D | Aug 19, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $1,000,000 | $12,000,000 | $11,000,000 |
| Reported amount sold | $1,000,000 | $8,424,490 | $7,424,490 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002029079-25-000001 · Later SEC source: 0002029079-25-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $12,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $8,424,490
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Likely investment adviser (not guaranteed)
Best-effort name match against Form ADV. Click through for AUM, employees, and disciplinary disclosures.
-
CONTINUITY PARTNERS GROUP, LLC
medium CRD 801-70784
Form D filings (2)
-
0002029079-25-000002D · Aug 19, 2025 · BiotechnologyOffering: $12,000,000Sold: $8,424,490
Compared with 0002029079-25-000001:
- Reported offering amount: $1,000,000 → $12,000,000
- Reported amount sold: $1,000,000 → $8,424,490
-
0002029079-25-000001D · Jun 4, 2025 · BiotechnologyOffering: $1,000,000Sold: $1,000,000